Roche Holding company profile

RO · SIX · CHF

Compare Roche Holding

Secondary listing. The primary listing is Roche Holding · SIX (CHF)

CHF 411.00Change from previous close: −0.77%Absolute change: −CHF 3.20

Close · November 17, 2026

Company profile

Roche Holding has 103,249 employees and is headquartered in Basel, Switzerland.

Based in Basel, Switzerland, Roche Holding AG was founded in 1896 and operates in pharmaceuticals and diagnostics. Its pharma portfolio covers therapeutic areas such as oncology, neurological disorders, ophthalmology, dermatology and transplantation. Its diagnostics business offers in vitro tests for diseases including cancer, diabetes and hepatitis, along with diagnostic instruments and digital health solutions. The group sells in Europe, North America, Latin America, Asia, Africa, Australia and New Zealand.

In the fiscal year ended December 2025, Roche reported revenue of CHF 63.4 billion, up 1.5% from the previous year, and net income of CHF 12.9 billion. The company has 103,249 employees and its headquarters are in Basel. Its shares are also listed on SIX.

Company facts

Industry
Drug Manufacturers - General
Headquarters
Grenzacherstrasse 124, 4070, Basel
Employees
103,249
Listing
RO · SIX
Currency
CHF
ISIN
CH0012032113
Website
roche.com

Roche Holding and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Roche HoldingROSwitzerland$392.79B103,24933.1%27.0
NovartisNOVNSwitzerland$305.16B75,26734.0%32.6
AstraZenecaAZNUnited Kingdom$287.12B96,10025.8%26.6
Novo NordiskNOVO.BDenmark$184.87B68,79450.8%11.2
SanofiSANFrance$116.52B74,84622.3%25.5
GSKGSKUnited Kingdom$102.04B66,84130.5%18.0

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Roche Holding with its competitors